BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Diabetes Drug Cuts Body Weight, Seeks FDA Approval as Obesity Treatment

  Data published in the New England Journal of Medicine shows the once-weekly dose of the glucagon-like peptide-1 (GLP-1) analog significantly reduced weight in patients over the course of 68 weeks.

  February 11, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Research Roundup: COVID-19 Brain Fog and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  February 11, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  Ensoma Launches with $70 Million Series A and Takeda Licensing Deal

  As part of the Takeda deal, Ensoma will do preclinical research for therapies in up to five rare disease indications, and both companies will work on Investigational New Drug-enabling studies.

  February 11, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• 

  How to Handle Time Off When You Work from Home and Can’t Travel

  It’s easy to feel guilty about taking time off when you’re working from home and not physically going on vacation. But your brain needs that vacation.

  February 11, 2021

   · 

  2 min read

   · 

  Laura Brothers
• 

  Policy

  Fresenius Kabi Hid “Dirty Laundry” from FDA, Pleads Guilty to Criminal Charges

  The cancer drugmaker pled guilty of violating the Federal Food, Drug and Cosmetic Act by failing to provide certain records to investigators in federal court.

  February 11, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Business

  BioSpace Movers & Shakers, Feb. 12

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  February 11, 2021

   · 

  6 min read

   · 

  Alex Keown
• 

  Drug Development

  New Vaccine Formulation Shows Promise for Alzheimer’s Target

  Switzerland-based AC Immune SA announced positive interim results from its ongoing Phase Ib/IIa clinical trial of ACI-35.030 for Alzheimer’s disease.

  February 11, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Career Advice

  6 Tips for Finding Work During the Coronavirus Pandemic

  Let’s review the six tips for finding work during the coronavirus pandemic.

  February 11, 2021

   · 

  4 min read

   · 

  Don Potochny
• 

  Bio NC

  Precision’s Stealth Cell Allogeneic CAR T Candidate Engineered for Persistence

  Precision BioSciences recently received a notice of allowance for a new patent for PBCAR19B, its stealth cell, CD19 allogeneic CAR T candidate for non-Hodgkin lymphoma.

  February 11, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  COVID-19 Vaccine Program Hiccups, Misses and Disasters

  There are some big surprises among the list of major players in the vaccine space who either dropped their programs or have been significantly delayed.

  February 11, 2021

   · 

  5 min read

   · 

  Mark Terry